Our Blog

New hope for alopecia areata


The inflammatory molecules that cause alopecia areata are increasingly understood. Tofacitinib is a drug that was being tested for psoriasis and was observed to improve alopecia areata(AA). Formal clinical trials are now showing promising results. This drug could be a great help for many patients with severe AA who have previously had few options.

Read more

Biologic drugs for psoriasis


The NHS in England currently funds biologic drug treatments for the most severely affected psoriasis patients. The main risks are a very small increased risk of infection . Many patients get an excellent life changing response

Read more